Cargando…

Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study

INTRODUCTION: diabetes mellitus is a major health problem worldwide. It is associated with high cardiovascular morbi-mortality especially coronary artery disease. Myocardial ischemia is often asymptomatic (silent myocardial ischemia) in people with type 2 diabetes mellitus thus making early diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mfeukeu-Kuate, Liliane, Meyanui, Vanessa Abongteh, Jingi, Ahmadou Musa, Ndobo-Koe, Valerie, Mballa, Franck, Ntep- Gweth, Marie, Etoga, Martine Etoa, Noubiap, Jean Jacques, Sobngwi, Eugène, Menanga, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338715/
https://www.ncbi.nlm.nih.gov/pubmed/35949456
http://dx.doi.org/10.11604/pamj.2022.42.41.34941
_version_ 1784760032169033728
author Mfeukeu-Kuate, Liliane
Meyanui, Vanessa Abongteh
Jingi, Ahmadou Musa
Ndobo-Koe, Valerie
Mballa, Franck
Ntep- Gweth, Marie
Etoga, Martine Etoa
Noubiap, Jean Jacques
Sobngwi, Eugène
Menanga, Alain
author_facet Mfeukeu-Kuate, Liliane
Meyanui, Vanessa Abongteh
Jingi, Ahmadou Musa
Ndobo-Koe, Valerie
Mballa, Franck
Ntep- Gweth, Marie
Etoga, Martine Etoa
Noubiap, Jean Jacques
Sobngwi, Eugène
Menanga, Alain
author_sort Mfeukeu-Kuate, Liliane
collection PubMed
description INTRODUCTION: diabetes mellitus is a major health problem worldwide. It is associated with high cardiovascular morbi-mortality especially coronary artery disease. Myocardial ischemia is often asymptomatic (silent myocardial ischemia) in people with type 2 diabetes mellitus thus making early diagnosis difficult. Silent myocardial ischemia is defined as the objective evidence of myocardial ischemia in the absence of chest discomfort or other angina equivalents. This study aimed to determine the prevalence and determinants of silent myocardial ischemia in a population of people with type 2 diabetes using exercise stress electrocardiography. METHODS: we carried out a cross-sectional study between January and April 2019 at the National Obesity Centre of the Yaounde Central Hospital. Patients with type 2 diabetes underwent a complete clinical evaluation, blood test, resting electrocardiogram (ECG), and exercise stress ECG according to the Bruce protocol. A positive stress test was defined as horizontal or down-sloping ST depression ≥ 1mm or upsloping ST depression of 2 mm or more 0.06 to 0.08 seconds after the J point. RESULTS: a total of 112 patients with diabetes (63 males and 49 females) were screened. The median age was 58 (IQR: 51 - 64) years. The median time from diabetes diagnosis was 8 (IQR: 5 - 12) years. Fifty-seven (50.4%) had hypertension, 78 (69.0%) had dyslipidemia, 66 (58.4%) were obese, 70 (61.9%) had poor glycemic control, and 23 (20.2%) were smokers. Sixty-five (58%) patients had a positive exercise stress ECG test. Factors independently associated with a positive stress test were abdominal obesity (aOR: 4.2, [95% CI: 1.4 - 12.8]) and Female sex (aOR: 2.5, [95% CI: 1.1 - 5.7]). CONCLUSION: the prevalence of silent myocardial ischemia was high in a population of asymptomatic patients. This was independently associated with abdominal obesity and female sex.
format Online
Article
Text
id pubmed-9338715
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-93387152022-08-09 Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study Mfeukeu-Kuate, Liliane Meyanui, Vanessa Abongteh Jingi, Ahmadou Musa Ndobo-Koe, Valerie Mballa, Franck Ntep- Gweth, Marie Etoga, Martine Etoa Noubiap, Jean Jacques Sobngwi, Eugène Menanga, Alain Pan Afr Med J Research INTRODUCTION: diabetes mellitus is a major health problem worldwide. It is associated with high cardiovascular morbi-mortality especially coronary artery disease. Myocardial ischemia is often asymptomatic (silent myocardial ischemia) in people with type 2 diabetes mellitus thus making early diagnosis difficult. Silent myocardial ischemia is defined as the objective evidence of myocardial ischemia in the absence of chest discomfort or other angina equivalents. This study aimed to determine the prevalence and determinants of silent myocardial ischemia in a population of people with type 2 diabetes using exercise stress electrocardiography. METHODS: we carried out a cross-sectional study between January and April 2019 at the National Obesity Centre of the Yaounde Central Hospital. Patients with type 2 diabetes underwent a complete clinical evaluation, blood test, resting electrocardiogram (ECG), and exercise stress ECG according to the Bruce protocol. A positive stress test was defined as horizontal or down-sloping ST depression ≥ 1mm or upsloping ST depression of 2 mm or more 0.06 to 0.08 seconds after the J point. RESULTS: a total of 112 patients with diabetes (63 males and 49 females) were screened. The median age was 58 (IQR: 51 - 64) years. The median time from diabetes diagnosis was 8 (IQR: 5 - 12) years. Fifty-seven (50.4%) had hypertension, 78 (69.0%) had dyslipidemia, 66 (58.4%) were obese, 70 (61.9%) had poor glycemic control, and 23 (20.2%) were smokers. Sixty-five (58%) patients had a positive exercise stress ECG test. Factors independently associated with a positive stress test were abdominal obesity (aOR: 4.2, [95% CI: 1.4 - 12.8]) and Female sex (aOR: 2.5, [95% CI: 1.1 - 5.7]). CONCLUSION: the prevalence of silent myocardial ischemia was high in a population of asymptomatic patients. This was independently associated with abdominal obesity and female sex. The African Field Epidemiology Network 2022-05-16 /pmc/articles/PMC9338715/ /pubmed/35949456 http://dx.doi.org/10.11604/pamj.2022.42.41.34941 Text en Copyright: Liliane Mfeukeu-Kuate et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mfeukeu-Kuate, Liliane
Meyanui, Vanessa Abongteh
Jingi, Ahmadou Musa
Ndobo-Koe, Valerie
Mballa, Franck
Ntep- Gweth, Marie
Etoga, Martine Etoa
Noubiap, Jean Jacques
Sobngwi, Eugène
Menanga, Alain
Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title_full Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title_fullStr Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title_full_unstemmed Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title_short Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study
title_sort prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in cameroon: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338715/
https://www.ncbi.nlm.nih.gov/pubmed/35949456
http://dx.doi.org/10.11604/pamj.2022.42.41.34941
work_keys_str_mv AT mfeukeukuateliliane prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT meyanuivanessaabongteh prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT jingiahmadoumusa prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT ndobokoevalerie prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT mballafranck prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT ntepgwethmarie prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT etogamartineetoa prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT noubiapjeanjacques prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT sobngwieugene prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy
AT menangaalain prevalenceanddeterminantsofsilentmyocardialischemiainpatientswithtype2diabetesincameroonacrosssectionalstudy